Cerebrospinal Fluid Amyloid-β (Aβ) as an Effect Biomarker for Brain Aβ Lowering Verified by Quantitative Preclinical AnalysesYasong Lu, Martin Pettersson, Elaine Tseng et al.|Journal of Pharmacology and Experimental Therapeutics|2012Cited by 36
Cerebrospinal Fluid β-Amyloid Turnover in the Mouse, Dog, Monkey and Human Evaluated by Systematic Quantitative AnalysesYasong Lu, David Riddell, Hugh A. Barton et al.|Neurodegenerative Diseases|2012Cited by 21
P4‐315: Evaluating amyloid‐beta processing using novel gamma‐secretase modulators in preclinical animal modelsKathleen M. Wood, Kelly R. Bales, Cathleen Gonzales et al.|Alzheimer s & Dementia|2015Cited by 1
P2–394: Characterization of beta‐amyloid 1–40 across species following treatment with beta‐secretase inhibitorsAshley Robshaw, David Riddell, Kevin Atchison et al.|Alzheimer s & Dementia|2013Cited by 0
Front & Back MatterRobert Christian Wolf, Satz Mengensatzproduktion, Philipp A. Thomann et al.|Neurodegenerative Diseases|2013Cited by 0